CN Patent

CN111201020A — 静脉内施用推注剂量美洛昔康的方法

Assigned to Badax Biological Co Ltd · Expires 2020-05-26 · 6y expired

What this patent protects

本公开涉及美洛昔康推注制剂以及静脉内施用其以治疗疼痛的方法，其可以提供适于管理急性中度至重度疼痛的快速疼痛缓解起效。

USPTO Abstract

本公开涉及美洛昔康推注制剂以及静脉内施用其以治疗疼痛的方法，其可以提供适于管理急性中度至重度疼痛的快速疼痛缓解起效。

Drugs covered by this patent

Patent Metadata

Patent number
CN111201020A
Jurisdiction
CN
Classification
—
Expires
2020-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Badax Biological Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.